Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication

PHASE3Enrolling by invitationINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG

Vonoprazan

Vonoprazan (20 mg bid, for 14 days)

DRUG

Esomeprazole 40mg

Esomeprazole (40 mg tid, for 14 days)

DRUG

Amoxicillin

Amoxicillin (750 mg qid, for 14 days)

Trial Locations (1)

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER